Towards a specific immunosuppression for pancreas and islet grafts

Clinical Transplantation

Volumn 14, Issue 3, 2000, Pages 242-245

  Jindal, Rahul M ^b   Dubernard, Jean Michel ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Immunosuppression; Pancreatic and islet transplantation; Post transplant diabetes mellitus

Indexed keywords

15 DEOXYSPERGUALIN; BREQUINAR; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; DIABETES MELLITUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

DIABETES MELLITUS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; TACROLIMUS;

EID: 0034106815     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140310.x     Document Type: Article

References (13)

1. JINDAL RM. Post-transplant diabetes mellitus - a review. Transplantation 1994: 58: 1289.
2. JINDAL RM, SIDNER RA, MILGROM ML. Post-transplant diabetes mellitus: the role of immunosuppression. Drug Safety 1997: 16: 242.
3. PIRSCH JD, MILLER J, DEIERHOI MH, VINCENTI F, FILO RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997: 63: 977.
4. JINDAL RM, POPSECU I, SCHWARTZ ME et al. Diabeto-genicity of FK506 versus cyclosporine in liver transplant recipients. Transplantation 1994: 58: 370.
5. VESCO L, BUSSON M, BEDROSSIAN J, BITKER MO, HIESSE C, LANG P. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 1996: 61: 1475.
6. GERSTEIN H, YUSUF S. Dysglycaemia and risk of cardiovascular disease. Lancet 1996: 347: 949.
7. AKER S, IVENS K, GUO Z, GRABENSEE B, HEERING P. Cardiovascular complications after renal transplantation. Transplant Proc 1998: 30: 2039.
8. STEGALL MD, EVERSON GT, SCHROTER G et al. Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. Hepatology 1997: 25: 173.
9. HRICIK DE, BARTUCCI MR, MOIR EJ, MAYES JT, SCHULAK JA. Effects of steroid withdrawal on post-transplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 1991: 51: 374.
10. CANZANELLO VJ, SCHWARTZ L, TALER SJ et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and Tacrolimus (FK506). Liver Transplant Surg 1997: 3: 1.
11. BARTLETT ST, SCHWEITZER E, JOHNSON LB et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation: a prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996: 224: 440.
12. GRUESSNER RWG, BURKE GW, STRATTA R et al. A multicenter analysis of the first experience with FK506 for the induction and rescue therapy after pancreas transplantation. Transplantation 1996: 61: 261.
13. STARZL TE, DEMETRIS AJ, TRUCCO M et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993: 17: 1127.